Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Sotos' syndrome
ADR ID BADD_A06238
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.11      Musculoskeletal and connective tissue disorders congenital
03.11.06      Musculoskeletal disorders congenital NEC
03.11.06.003      Sotos' syndrome
15      Musculoskeletal and connective tissue disorders
15.11      Musculoskeletal and connective tissue disorders congenital
15.11.06      Musculoskeletal disorders congenital NEC
15.11.06.003      Sotos' syndrome
Description Congenital or postnatal overgrowth syndrome most often in height and occipitofrontal circumference with variable delayed motor and cognitive development. Other associated features include advanced bone age, seizures, NEONATAL JAUNDICE; HYPOTONIA; and SCOLIOSIS. It is also associated with increased risk of developing neoplasms in adulthood. Mutations in the NSD1 protein and its HAPLOINSUFFICIENCY are associated with the syndrome. [MeSH]
MedDRA Code 10064387
MeSH ID D058495
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Sotos' syndrome | Cerebral gigantism | Sotos Syndrome | Syndrome, Sotos | Sotos Sequence | Sequence, Sotos | Sotos' Syndrome | Soto Syndrome | Soto's Syndrome | Syndrome, Sotos' | Cerebral Gigantism | Cerebral Gigantisms | Gigantism, Cerebral | Gigantisms, Cerebral
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00792Eptifibatide--
The 1th Page    1    Total 1 Pages